Part 8/11:
Recent advancements in treatment regimes involving chemotherapy and chemoradiation have shown the capability to reduce mortality rates dramatically. These treatments could lead to a notable decrease in the chance of recurrence, making them promising options for patients.
Pioneering Treatments for Pancreatic Cancer
Pancreatic cancer is notoriously challenging to detect early, resulting in high mortality rates. To combat this, the FDA has recently approved a targeted therapy drug called Bangri, which zeroes in on tumors with specific genetic alterations. Trials show promising results, with a high percentage of tumors shrinking significantly among patients treated with Bangri.